{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:09Z","timestamp":1753890609708,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>A paradoxical embolism is defined as a venous thrombus that crosses through a heart defect, into the systemic circulation, usually through a patent foramen ovale. Treatment varies between closure of patent foramen ovale vs. medical management based on a variety of individual risk factors and the cardiac defect's characteristics. We describe a case of paradoxical stroke complicated by hemorrhagic conversion, ultimately requiring an IVC filter.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1395542","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:36:43Z","timestamp":1726634203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of PFO in paradoxical embolic stroke with hemorrhagic conversion: a case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Michael","family":"Sabina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aqeel","family":"Khanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Rigdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/NEJMp1700218","article-title":"Patent foramen ovale after cryptogenic stroke\u2014assessing the evidence for closure","volume":"377","author":"Farb","year":"2017","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/STROKEAHA.117.018153","article-title":"Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review","volume":"49","author":"Saver","year":"2018","journal-title":"Stroke"},{"key":"B3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"B4","article-title":"Paradoxical embolism","volume-title":"StatPearls","author":"Hakman","year":"2024"},{"key":"B5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","article-title":"Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke","volume":"77","author":"Elgendy","year":"2020","journal-title":"JAMA Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"volume-title":"PFO closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-Associated Stroke in Patients Aged 60\u201380 Years (CLOSE-2)","year":"2022","author":"Mas","key":"B12"},{"volume-title":"Prospective Registry of Elderly ESUS with PFO (COACH_ESUS)","year":"2022","key":"B13"},{"key":"B14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5853\/jos.2023.01599","article-title":"Cerebrovascular events in older patients with patent foramen ovale: current Status and future perspectives","volume":"25","author":"Farjat-Pasos","year":"2023","journal-title":"J Stroke"},{"key":"B15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/2013.jamaneurol.547","article-title":"Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke","volume":"70","author":"Yeo","year":"2013","journal-title":"JAMA Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/STROKEAHA.114.004889","article-title":"Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism","volume":"45","author":"Robbins","year":"2014","journal-title":"Stroke"},{"key":"B17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.2019.9346","article-title":"Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial","volume":"322","author":"Johnston","year":"2019","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1161\/STROKEAHA.111.644815","article-title":"Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score","volume":"43","author":"Mazya","year":"2012","journal-title":"Stroke"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/archneur.65.9.noc70105","article-title":"Anticoagulation after cardioembolic stroke: to bridge or not to bridge?","volume":"65","author":"Hallevi","year":"2008","journal-title":"Arch Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3892\/etm.2015.2186","article-title":"Correlation between the -1562C\/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke","volume":"9","author":"Zhang","year":"2015","journal-title":"Exp Ther Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/01.str.0000023577.65990.4e","article-title":"Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume","volume":"33","author":"Selim","year":"2002","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.15761\/VDT.1000130","article-title":"Hemorrhagic transformation of ischemic stroke","volume":"2","author":"Laszl\u00f3","year":"2017","journal-title":"Vasc Dis Ther"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1395542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:36:46Z","timestamp":1726634206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1395542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":22,"alternative-id":["10.3389\/fcvm.2024.1395542"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1395542","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"article-number":"1395542"}}